Lindborg Stacy
- SEC CIK
- 0001813667
No open-market purchases or sales filed in the past year.
Current role at each company
- IMNN Imunon, Inc.President and CEOas of Sep 15, 2026
- BCLI Brainstorm Cell Therapeutics Inc.Directoras of May 20, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lindborg Stacy as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IMNN Imunon, Inc.
President and CEO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2024 (view filing) | Aug 15 | 1 day | Lindborg StacyPresident and CEO | PPurchaseImunon Common Stock | +25.0K | $0.98 | +$24.5K | +10.5%264.2K after |
BCLI Brainstorm Cell Therapeutics Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 5, 2023 (view filing) | Sep 1 | 4 days | Lindborg StacyCo-Chief Executive Officer | PPurchase | +11.5K | $1.77 | +$20.4K | +6.8%181.5K after |